Tuesday, October 27, 2020 4:05:02 PM
Kala Pharmaceuticals Down Over 14%, on Pace for Largest Percent Decrease Since October 2018 --
12:35 pm ET October 27, 2020 (Dow Jones) Print
Kala Pharmaceuticals, Inc. (KALA) is currently at $6.61, down $1.11 or 14.38%
-- Would be lowest close since March 16, 2020, when it closed at $6.13
-- On pace for largest percent decrease since Oct. 3, 2018, when it fell 15.52%
-- Earlier Tuesday, Kala Pharmaceuticals announced the U.S. Food and Drug Administration has approved Eysuvis for the short-term treatment of the signs and symptoms of dry-eye disease. The company said Eysuvis is the first approved prescription therapy specifically for short-term treatment of the chronic, episodic disease that affects the tears and ocular surface
-- Currently down five of the past six days
-- Currently down three consecutive days; down 15.26% over this period
-- Worst three day stretch since the three days ending Sept. 24, 2020, when it fell 15.77%
-- Down 11.87% month-to-date
-- Up 79.13% year-to-date; on pace for best year on record (Based on available data back to July 20, 2017)
-- Down 75.08% from its all-time closing high of $26.53 on Sept. 14, 2017
-- Up 89.94% from 52 weeks ago (Oct. 29, 2019), when it closed at $3.48
-- Down 52.07% from its 52-week closing high of $13.79 on June 2, 2020
-- Up 89.94% from its 52-week closing low of $3.48 on Oct. 29, 2019
-- Traded as low as $6.07; lowest intraday level since March 17, 2020, when it hit $5.04
-- Down 21.37% at today's intraday low; largest intraday percent decrease since Jan. 5, 2018, when it fell as much as 31.85%
Recent KALA News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/06/2024 08:06:16 PM
- KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:02:06 PM
- KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/01/2024 04:15:09 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/31/2024 08:08:20 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/25/2024 08:10:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/17/2024 09:22:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 09:34:43 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 07/09/2024 12:54:55 AM
- KALA BIO Announces $12,500,000 Private Placement • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 12:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 12:00:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 12:00:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 12:00:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 12:00:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 12:00:12 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/30/2024 08:03:12 PM
- KALA BIO to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:08:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:06:15 PM
- KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:30:19 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM